ERCC1 rs11615 Single Nucleotide Polymorphism in Bladder Cancer Patients and Safety Outcomes of Cisplatin-Based Chemotherapy

Prognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer

ERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy

Second-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Single Institution Experience

Association of Genetic Polymorphism of ABCG2 Gene and the Occurrence of Oxaliplatin-Induced Peripheral Neuropathy in Patients with Colorectal Cancer

Osimertinib with Platinum Based Chemotherapy in Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non Small Cell Lung Cancer (NSCLC)

Targeted Therapy in Non-Small Cell Lung Cancer: Review Article

Micronucleus Assay in Patients with Lung Cancer, Chronic Obstructive Pulmonary Disease and Non-Smoker Control

Association of TP53 codon 72 polymorphisms and non-small cell lung cancer risk in the Egyptian population: a case-control study

Association Between XRCC3 Thr241Met Gene Polymorphism and Susceptibility to Urothelial Carcinoma of the Bladder